Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03642639 · ClinicalTrials.gov registry record · NA

A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms

A NA study of Aneurysms, sponsored by Cerenovus, Part of DePuy Synthes Products.

Completed
Registry status
NA
Development phase
809
Enrollment target
20
Study locations

NCT03642639 is a NA study of Aneurysms that has completed, run by Cerenovus, Part of DePuy Synthes Products. The registered enrollment target is 809 participants. The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03642639, a NA study of Aneurysms, has completed, sponsored by Cerenovus, Part of DePuy Synthes Products.

COMPLETED
Registry status
NA
Development phase
809 participants
Enrollment target
20
Study locations

Study Summary

A post-market registry evaluating ruptured/unruptured aneurysms treated with MICRUSFRAME and GALAXY coils

Conditions Studied

Interventions

  • DEVICE MICRUSFRAME and GALAXY coils

Study Locations (20)

New York

  • University of Buffalo - Buffalo
  • Mount Sinai Hospital - New York
  • Stony Brook University - Stony Brook
  • Westchester Medical Center - Valhalla

Florida

  • University of Florida - Gainesville
  • Baptist Medical Center - Jacksonville
  • University of Miami - Miami

Illinois

  • Rush University - Chicago
  • University of Illinois - Chicago
  • Javon Bea Hospital - Rockford

California

  • Mercy San Juan Medical Center - Carmichael
  • University of California Irvine - Orange

Arizona

  • University of Arizona - Tucson

Georgia

  • Memorial Health University - Savannah

Kentucky

  • Norton Healthcare - Louisville

Maine

  • Maine Medical Center - Scarborough

Trial Details

FieldValue
Enrollment Target 809 participants
Start Date 2018-08-23
Est. Completion 2025-06-12
Phase NA

What the Registry Record Tells You About NCT03642639

The ClinicalTrials.gov registry entry for NCT03642639 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 809 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cerenovus, Part of DePuy Synthes Products, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aneurysms appearing as the primary indexed condition, and to 1 intervention - of which MICRUSFRAME and GALAXY coils is the first listed.

NCT03642639 reports 20 study locations spanning 12 distinct geographic areas - top geographies include New York, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT03642639 about?

NCT03642639 is a clinical study titled "A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms". A post-market registry evaluating ruptured/unruptured aneurysms treated with MICRUSFRAME and GALAXY coils

What is the current status of trial NCT03642639?

This trial is currently completed. It is a NA study. The enrollment target is 809 participants. The study started on 2018-08-23. Estimated completion is 2025-06-12.

What conditions does trial NCT03642639 study?

This clinical trial studies the following conditions: Aneurysms.

What interventions are being tested in trial NCT03642639?

The interventions under investigation include: MICRUSFRAME and GALAXY coils (DEVICE).

Who is sponsoring clinical trial NCT03642639?

This trial is sponsored by Cerenovus, Part of DePuy Synthes Products, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03642639 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.